Genmab's Q4 2024 results impress with $897.4M revenue and 29% growth. GMAB's balance sheet is strong with nearly $3 billion ...

Leerink Partnrs upgraded shares of Genmab A/S (NASDAQ:GMAB – Free Report) from a hold rating to a strong-buy rating in a ...

Media ReleaseCOPENHAGEN, Denmark; February 19, 2025Genmab A/S (Nasdaq: GMAB) announced today that its Chief Financial Officer Anthony Pagano and Chief Development Officer Judith Klimovsky will ...

Genmab (GMAB) announced that the Japan Ministry of Health, Labour and Welfare has approved EPKINLY or epcoritamab, for the treatment of ...

Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Genmab (GMAB – Research Report) today and set a price target of $31.00. The ...

Research analysts at Leerink Partnrs issued their Q3 2025 EPS estimates for shares of Genmab A/S in a report issued on Thursday, February 13th. Leerink Partnrs analyst J. Chang forecasts that the ...

A high omega-3, low omega-6 diet with fish oil led to a significant reduction in a biomarker for prostate cancer progression ...

The largest life sciences association in the state recognized those driving discovery during its 32nd annual dinner meeting ...

Harding Loevner International Equity ADR composite fell 7.9%, gross, behind the 7.5% decline of the MSCI ACWI ex US Index.

Prodoscore, a leading provider of employee productivity and data intelligence software, today unveiled a new, first-of-its-kind AI functionality designed to enhance the performance of employees and ...

FULLERTON, CA / ACCESS Newswire / February 20, 2025 / Verde Bioresins, a pioneer in sustainable polymer technology, announces its partnership with Mr. Chain, a leading U.S. manufacturer of plastic ...